These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 30241508

  • 1. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B, Dispan R, Radinahamed P, Kitiyakara C.
    BMC Nephrol; 2018 Sep 21; 19(1):246. PubMed ID: 30241508
    [Abstract] [Full Text] [Related]

  • 2. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L, Li XQ, Chang DY, Zhang H, Li JJ, Wu SL, Zhang LX, Chen M, Zhao MH.
    Nephrol Dial Transplant; 2020 Feb 01; 35(2):291-297. PubMed ID: 30357416
    [Abstract] [Full Text] [Related]

  • 3. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A, Bdeer Sel-A, El-Sokkary RH.
    Mol Cell Biochem; 2015 Oct 01; 408(1-2):25-35. PubMed ID: 26104579
    [Abstract] [Full Text] [Related]

  • 4. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N, Skupien J, Smiles AM, Yamanouchi M, Niewczas MA, Galecki AT, Duffin KL, Breyer MD, Pullen N, Bonventre JV, Krolewski AS.
    Kidney Int; 2018 May 01; 93(5):1198-1206. PubMed ID: 29398132
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY, Chen FQ.
    Diabetes Res Clin Pract; 2009 Feb 01; 83(2):215-9. PubMed ID: 19097668
    [Abstract] [Full Text] [Related]

  • 6. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
    Betz BB, Jenks SJ, Cronshaw AD, Lamont DJ, Cairns C, Manning JR, Goddard J, Webb DJ, Mullins JJ, Hughes J, McLachlan S, Strachan MWJ, Price JF, Conway BR.
    Kidney Int; 2016 May 01; 89(5):1125-1135. PubMed ID: 27083286
    [Abstract] [Full Text] [Related]

  • 7. Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
    Chanrat E, Worawichawong S, Radinahamed P, Sathirapongsasuti N, Nongnuch A, Assanatham M, Udomsubpayakul U, Kitiyakara C.
    Cytokine; 2018 Apr 01; 104():1-7. PubMed ID: 29414320
    [Abstract] [Full Text] [Related]

  • 8. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
    Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH.
    Cytokine; 2009 Jul 01; 47(1):37-42. PubMed ID: 19409809
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion of epidermal growth factor and rapid loss of kidney function.
    Norvik JV, Harskamp LR, Nair V, Shedden K, Solbu MD, Eriksen BO, Kretzler M, Gansevoort RT, Ju W, Melsom T.
    Nephrol Dial Transplant; 2021 Sep 27; 36(10):1882-1892. PubMed ID: 33068410
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-6 and epidermal growth factor as noninvasive biomarkers of progression in chronic glomerulonephritis.
    Idasiak-Piechocka I, Miedziaszczyk M, Woźniak A, Pawliczak E, Kaczmarek E, Oko A.
    Am J Physiol Cell Physiol; 2023 Nov 01; 325(5):C1267-C1275. PubMed ID: 37721004
    [Abstract] [Full Text] [Related]

  • 11. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
    Chang LH, Chang TT, Chu CH, Huang CC, Lin LY.
    Clin Chim Acta; 2024 May 15; 558():117880. PubMed ID: 38555050
    [Abstract] [Full Text] [Related]

  • 12. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
    Camilla R, Brachemi S, Pichette V, Cartier P, Laforest-Renald A, MacRae T, Madore F, Troyanov S.
    J Nephrol; 2011 May 15; 24(1):60-7. PubMed ID: 20437404
    [Abstract] [Full Text] [Related]

  • 13. Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children.
    Li B, Zhang Y, Wang F, Nair V, Ding F, Xiao H, Yao Y, Kretzler M, Ju W, Ding J.
    Pediatr Nephrol; 2018 Oct 15; 33(10):1731-1739. PubMed ID: 29948307
    [Abstract] [Full Text] [Related]

  • 14. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
    Greenberg JH, Abraham AG, Xu Y, Schelling JR, Feldman HI, Sabbisetti VS, Ix JH, Jogalekar MP, Coca S, Waikar SS, Shlipak MG, Warady BA, Vasan RS, Kimmel PL, Bonventre JV, Denburg M, Parikh CR, Furth S, CKD Biomarkers Consortium, CKD Biomarker consortium.
    J Am Soc Nephrol; 2021 Oct 15; 32(10):2664-2677. PubMed ID: 34544821
    [Abstract] [Full Text] [Related]

  • 15. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T, Tanaka S, Sone H, Ishibashi S, Matsunaga S, Ohashi Y, Akanuma Y, Haneda M, Katayama S.
    J Diabetes Complications; 2017 Feb 15; 31(2):473-478. PubMed ID: 27396240
    [Abstract] [Full Text] [Related]

  • 16. Urinary Epidermal Growth Factor: A Promising "Next Generation" Biomarker in Kidney Disease.
    Cortvrindt C, Speeckaert R, Delanghe JR, Speeckaert MM.
    Am J Nephrol; 2022 Feb 15; 53(5):372-387. PubMed ID: 35537382
    [Abstract] [Full Text] [Related]

  • 17. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Knowler WC, Rovin BH, Wu H, Klein JB, Mifflin TE, Feldman HI, Vasan RS, Kimmel PL, Kusek JW, Mauer M, CKD Biomarkers Consortium and the RASS Investigators.
    Nephrol Dial Transplant; 2015 Apr 15; 30(4):599-606. PubMed ID: 25648911
    [Abstract] [Full Text] [Related]

  • 18. Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial.
    Nadkarni GN, Rao V, Ismail-Beigi F, Fonseca VA, Shah SV, Simonson MS, Cantley L, Devarajan P, Parikh CR, Coca SG.
    Clin J Am Soc Nephrol; 2016 Aug 08; 11(8):1343-1352. PubMed ID: 27189318
    [Abstract] [Full Text] [Related]

  • 19. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C, Wang Q, Lv C, Qin N, Lei S, Yuan Q, Wang G.
    Diabetes Res Clin Pract; 2014 Nov 08; 106(2):343-50. PubMed ID: 25263500
    [Abstract] [Full Text] [Related]

  • 20. The next generation: Urinary epidermal growth factor is associated with an early decline in kidney function in children and adolescents with type 1 diabetes mellitus.
    Ledeganck KJ, den Brinker M, Peeters E, Verschueren A, De Winter BY, France A, Dotremont H, Trouet D.
    Diabetes Res Clin Pract; 2021 Aug 08; 178():108945. PubMed ID: 34245799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.